CompaniesKenta Biotech

Kenta Biotech

defunct
About

Defunct Company

Areas of Focus

Categories

Terminally AcquiredBankrupt, Merged, Sold, Renamed or Otherwise Defunct
Clinical Trials (4)
View all

Total Trials

4

As Lead Sponsor

4

As Collaborator

0

Total Enrollment

537

By Phase

PHASE1/PHASE2: 1

By Status

COMPLETED: 3RECRUITING: 1
Clinical Trials Pipeline4 trials
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Phase 1/2
Phase 2/3
N/A
2007
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
2026
Today
NCT05016258
Hover over trial bars to see details

Recent Trials

NCT05016258Lead Sponsor
"Performance and Safety Use of the Mono Block Implant KONTACT MB"
N/ARecruiting
159 participants
Started: Jan 26, 2022 · Completed: Oct 31, 2025
NCT05016401Lead Sponsor
"Performance and Safety of Use of the KONTACT PERIO LEVEL Transgingival Titanium Dental Implant"
N/ACompleted
199 participants
Started: Nov 6, 2020 · Completed: Feb 2, 2023
NCT03582657Lead Sponsor
"Performance and Safety Use of the Nanostructured Titanium Dental Implant KONTACT N"
N/ACompleted
164 participants
Started: Feb 4, 2019 · Completed: Jan 13, 2022
NCT00851435Lead Sponsor
Safety and Pharmacokinetics of KBPA-101 in Hospital Acquired Pneumonia Caused by O11 Pseudomonas Aeruginosa
PHASE1/PHASE2Completed
15 participants
Started: Feb 29, 2008 · Completed: Jul 31, 2009
Related Companies
Aridis Pharmaceuticals
acquired